Diacerein attenuates vascular dysfunction by reducing inflammatory response and insulin resistance in type 2 diabetic rats

被引:13
|
作者
He, An [1 ]
Shen, Jian [1 ]
Xue, Yuzhou [1 ]
li, Xiang [1 ]
Li, Yuanjing [1 ]
Huang, Longxiang [1 ]
Lv, Dingyi [1 ]
Luo, Minghao [1 ]
机构
[1] First Affiliated Hosp Chongqing Med Univ, Div Cardiol, Chongqing 400016, Peoples R China
关键词
Diacerein; Diabetes; Vascular function; OXIDATIVE STRESS; ENOS; RELAXATION; MELATONIN; KIDNEY; INJURY;
D O I
10.1016/j.bbrc.2021.11.017
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aim: To examine the effect of diacerein on vascular dysfunction in type 2 diabetic rats and elucidate the mechanism of diacerein. Methods: In a rat model, type 2 diabetes was induced by high-fat diet and streptozotocin. Vascular function was assessed in vascular reactivity experiment. The effect of diacerein (10 or 20 mg/kg/day) on blood glucose, inflammation and insulin signaling, and modulators in vascular tissue in diabetic rats were investigated by molecular and biochemical approaches. Results: In this study, diacerein inhibited diabetes-induced vascular dysfunction. Diacerein treatment normalized blood glucose, insulin tolerance test, inflammatory cytokine levels and nitric oxide synthases expression in diabetic rats. Moreover, diacerein inhibited NF-KB and NLRP3 pathways and activated in-sulin signaling pathway related proteins IRS-1 and AKT in diabetic rats. Conclusion: Diacerein improved vascular function effectively in diabetic rats by suppressing inflamma-tion and reducing insulin resistance. These results suggest that diacerein may represent a novel therapy for patients with diabetes. (c) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:68 / 74
页数:7
相关论文
共 50 条
  • [41] Proteasome dysfunction contributes to endoplasmic reticulum stress and insulin resistance in type 2 diabetic liver
    Otoda, T.
    Misu, H.
    Kurita, S.
    Yamamoto, M.
    Ota, T.
    Shima, K. R.
    Iseki, S.
    Murata, S.
    Tanaka, K.
    Kaneko, S.
    Takamura, T.
    DIABETOLOGIA, 2010, 53
  • [42] Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes
    Fontes-Carvalho, Ricardo
    Ladeiras-Lopes, Ricardo
    Bettencourt, Paulo
    Leite-Moreira, Adelino
    Azevedo, Ana
    CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [43] Relationship between impaired vascular reactivity, insulin resistance, and vascular inflammation in Hispanic type 2 diabetic individuals
    Fernandez, M
    Wajcberg, E
    Defilippis, E
    Mandarino, L
    Kellog, D
    Cusi, KN
    Defronzo, R
    Cersosimo, E
    DIABETES, 2004, 53 : A177 - A177
  • [44] Insulin resistance and endothelial dysfunction in type 2 diabetic patients with non-alcoholic steatohepatitis
    Kawashima, S.
    Suzuki, M.
    Kaneto, H.
    Imano, E.
    Haruna, Y.
    Nishimura, Y.
    Kawashima, A.
    Hatazaki, M.
    Matsuoka, T. -A.
    Yamasaki, Y.
    Matsuhisa, M.
    DIABETIC MEDICINE, 2009, 26 (06) : 662 - 663
  • [45] Chrysin, an anti-inflammatory molecule, abrogates renal dysfunction in type 2 diabetic rats
    Ahad, Amjid
    Ganai, Ajaz Ahmad
    Mujeeb, Mohd
    Siddiqui, Waseem Ahmad
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2014, 279 (01) : 1 - 7
  • [46] Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes
    Natali, A
    Toschi, E
    Baldeweg, S
    Ciociaro, D
    Favilla, S
    Saccà, L
    Ferrannini, E
    DIABETES, 2006, 55 (04) : 1133 - 1140
  • [47] Associations of Fetuin-A Levels With Insulin Resistance and Vascular Complications in Type 2 Diabetic Patients
    Jung, Chan-Hee
    Kim, Bo-Yeon
    Kim, Chul-Hee
    Kang, Sung-Koo
    Mok, Ji-Oh
    DIABETES, 2012, 61 : A124 - A124
  • [48] A new antidiabetic compound attenuates inflammation and insulin resistance in Zucker diabetic fatty rats
    Lu, Min
    Patsouris, David
    Li, Pingping
    Flores-Riveros, Jaime
    Frincke, James M.
    Watkins, Steve
    Schenk, Simon
    Olefsky, Jerrold M.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2010, 298 (05): : E1036 - E1048
  • [49] Reducing vascular disease risk in the type 2 diabetic patientt
    Brown, W. Virgil
    Goldberg, Ronald B.
    Lopes-Virella, Maria
    Reaven, Peter
    JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (01) : 3 - 11
  • [50] SORBITOL DEHYDROGENASE INHIBITION (SDI) ATTENUATES SCIATIC-NERVE VASCULAR DYSFUNCTION IN DIABETIC RATS
    WILLIAMSON, J
    CHANG, K
    ALLISON, W
    SMITH, S
    BURGAN, J
    TILTON, R
    DIABETES, 1993, 42 : A194 - A194